Scarica l'app Stockscreener
473.36
3.17%
-15.49
Dopo l'orario di chiusura:
473.15
-0.21
-0.04%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché TMO Giù?
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Precedente Chiudi:
$488.85
Aprire:
$489.615
Volume 24 ore:
1.68M
Relative Volume:
0.75
Capitalizzazione di mercato:
$175.85B
Reddito:
$44.56B
Utile/perdita netta:
$6.72B
Rapporto P/E:
26.69
EPS:
17.7387
Flusso di cassa netto:
$6.29B
1 W Prestazione:
-0.22%
1M Prestazione:
-9.16%
6M Prestazione:
+1.96%
1 anno Prestazione:
-7.49%
Intervallo 1D:
$471.83
$490.75
Intervallo di 1 settimana:
$470.00
$499.95
Portata 52W:
$385.46
$643.99
Thermo Fisher Scientific Inc Stock (TMO) Company Profile
Nome
Thermo Fisher Scientific Inc
Settore
Industria
Telefono
(781) 622-1000
Indirizzo
168 THIRD AVENUE, WALTHAM, MA
Compare TMO vs DHR, IDXX, A, WAT
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
TMO
Thermo Fisher Scientific Inc
|
473.36 | 175.85B | 44.56B | 6.72B | 6.29B | 17.74 |
DHR
Danaher Corp
|
181.52 | 128.46B | 24.57B | 3.60B | 5.26B | 5.051 |
IDXX
Idexx Laboratories Inc
|
558.32 | 44.46B | 4.30B | 1.06B | 1.04B | 13.08 |
A
Agilent Technologies Inc
|
110.24 | 31.15B | 7.07B | 1.29B | 993.00M | 4.5355 |
WAT
Waters Corp
|
289.16 | 28.37B | 3.17B | 642.63M | 516.49M | 10.77 |
Thermo Fisher Scientific Inc Stock (TMO) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-03-27 | Iniziato | DZ Bank | Buy |
| 2025-12-11 | Aggiornamento | Citigroup | Neutral → Buy |
| 2025-12-09 | Iniziato | Goldman | Buy |
| 2025-12-08 | Aggiornamento | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2025-12-02 | Ripresa | Morgan Stanley | Overweight |
| 2025-12-01 | Aggiornamento | HSBC Securities | Hold → Buy |
| 2025-09-11 | Aggiornamento | Barclays | Equal Weight → Overweight |
| 2025-08-19 | Iniziato | William Blair | Outperform |
| 2025-07-24 | Downgrade | HSBC Securities | Buy → Hold |
| 2025-07-11 | Aggiornamento | Scotiabank | Sector Perform → Sector Outperform |
| 2025-07-09 | Downgrade | UBS | Buy → Neutral |
| 2025-01-10 | Aggiornamento | Bernstein | Mkt Perform → Outperform |
| 2024-12-23 | Iniziato | Scotiabank | Sector Perform |
| 2024-10-14 | Iniziato | Redburn Atlantic | Buy |
| 2024-10-01 | Iniziato | Stephens | Overweight |
| 2024-08-28 | Iniziato | Wells Fargo | Overweight |
| 2024-06-03 | Ripresa | Jefferies | Buy |
| 2024-03-18 | Ripresa | Citigroup | Neutral |
| 2024-01-24 | Downgrade | Barclays | Overweight → Equal Weight |
| 2024-01-08 | Downgrade | Bernstein | Outperform → Mkt Perform |
| 2023-12-18 | Iniziato | HSBC Securities | Buy |
| 2023-12-13 | Iniziato | Wolfe Research | Outperform |
| 2023-10-26 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2023-10-25 | Aggiornamento | Wells Fargo | Underweight → Equal Weight |
| 2023-09-28 | Iniziato | Bernstein | Outperform |
| 2023-09-06 | Ripresa | Citigroup | Buy |
| 2023-07-19 | Iniziato | Raymond James | Outperform |
| 2023-07-19 | Reiterato | Robert W. Baird | Outperform |
| 2023-07-13 | Aggiornamento | Credit Suisse | Neutral → Outperform |
| 2023-04-04 | Reiterato | Barclays | Overweight |
| 2022-12-14 | Iniziato | Deutsche Bank | Buy |
| 2022-12-07 | Iniziato | RBC Capital Mkts | Outperform |
| 2022-10-27 | Downgrade | The Benchmark Company | Buy → Hold |
| 2022-08-25 | Iniziato | Credit Suisse | Neutral |
| 2022-04-25 | Downgrade | Wells Fargo | Equal Weight → Underweight |
| 2022-01-26 | Ripresa | Barclays | Overweight |
| 2021-10-20 | Aggiornamento | Citigroup | Neutral → Buy |
| 2021-10-15 | Ripresa | Cowen | Outperform |
| 2021-08-05 | Ripresa | Credit Suisse | Outperform |
| 2021-07-16 | Iniziato | The Benchmark Company | Buy |
| 2021-03-18 | Aggiornamento | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2021-03-03 | Iniziato | Barclays | Overweight |
| 2021-01-08 | Aggiornamento | Credit Suisse | Neutral → Outperform |
| 2020-12-16 | Downgrade | Citigroup | Buy → Neutral |
| 2020-12-02 | Iniziato | Goldman | Buy |
| 2020-11-10 | Iniziato | KeyBanc Capital Markets | Sector Weight |
| 2020-09-30 | Iniziato | Atlantic Equities | Overweight |
| 2020-09-14 | Iniziato | Morgan Stanley | Overweight |
| 2020-08-20 | Ripresa | JP Morgan | Overweight |
| 2020-07-15 | Aggiornamento | Cleveland Research | Neutral → Buy |
| 2020-07-07 | Reiterato | Needham | Buy |
| 2020-04-23 | Reiterato | Needham | Buy |
| 2020-01-31 | Reiterato | Needham | Buy |
| 2020-01-22 | Iniziato | Credit Suisse | Neutral |
| 2020-01-08 | Iniziato | Wells Fargo | Equal Weight |
| 2020-01-07 | Iniziato | Citigroup | Buy |
| 2019-11-15 | Iniziato | Stifel | Buy |
| 2019-07-25 | Reiterato | Needham | Buy |
| 2019-07-16 | Downgrade | Needham | Strong Buy → Buy |
| 2019-05-30 | Iniziato | Wolfe Research | Outperform |
| 2019-05-23 | Reiterato | Needham | Strong Buy |
| 2019-04-22 | Reiterato | Needham | Strong Buy |
| 2019-04-16 | Reiterato | BofA/Merrill | Buy |
Mostra tutto
Thermo Fisher Scientific Inc Borsa (TMO) Ultime notizie
Wedge Capital Management L L P NC Sells 6,634 Shares of Thermo Fisher Scientific Inc. $TMO - MarketBeat
Canoe Financial LP Decreases Position in Thermo Fisher Scientific Inc. $TMO - MarketBeat
Assenagon Asset Management S.A. Has $6.22 Million Stock Holdings in Thermo Fisher Scientific Inc. $TMO - MarketBeat
Generate Investment Management Ltd Has $20.66 Million Stake in Thermo Fisher Scientific Inc. $TMO - MarketBeat
Thermo Fisher Scientific Shares Sold by DAVENPORT & Co LLC - National Today
Eagle Rock Investment Company LLC Boosts Stock Position in Thermo Fisher Scientific Inc. $TMO - MarketBeat
Thermo Fisher Scientific Inc. $TMO Shares Sold by DAVENPORT & Co LLC - MarketBeat
Thermo Fisher Scientific Inc. (NYSE:TMO) Receives Consensus Rating of "Moderate Buy" from Analysts - MarketBeat
Deal Dispatch: Estée Lauder Considers Merger, KKR Buys Nothing Bundt Cakes, Amazon Acquires Fauna Robotics - Benzinga
Thermo Fisher Scientific Inc Stock (TMO) Moved Down by 3.31% on Mar 27: What Investors Need To Know - TradingKey
Vanguard Amends 13G: Reports 0 Shares in Thermo Fisher (TMO) - Stock Titan
Thermo Fisher Scientific collaborates with SHL Medical and expands Ridgefield site - ROI-NJ
Thermo Fisher Scientific (NYSE:TMO) Earns Buy Rating from Analysts at DZ Bank - MarketBeat
What You Need to Know Ahead of Thermo Fisher Scientific's Earnings Release - Barchart
Thermo Fisher and SHL Medical collaborate to deliver fully integrated drug-device solutions - BioSpectrum Asia
Is Thermo Fisher Scientific (TMO) one of the best conservative stocks to buy right now? - MSN
U.S. Sterility Testing Market Set to Boom Rapidly by 2033 | Thermo - openPR.com
Thermo Fisher Sci. stock faces pressure amid life sciences slowdown and acquisition scrutiny as of M - AD HOC NEWS
Thermo Fisher, SHL Medical collab on drug delivery device production - Drug Delivery Business
Thermo Fisher and SHL Medical partner on integrated drug device solutions - PharmiWeb.com
Thermo Fisher Scientific and SHL Medical Collaborate to Deliver Fully Integrated Drug-Device Solutio - PharmiWeb.com
Thermo Fisher Scientific and SHL Medical Collaborate to Deliver Fully Integrated Drug-Device Solutions - BioSpace
Thermo Fisher completes $8.9B buyout of Clario - MedTech Dive
Thermo Fisher Scientific Launches PPD CorEvitas Alzheimer’s Registry - Contract Pharma
Thermo Fisher Scientific and SHL Medical collaborate to deliver fully integrated Drug-Device Solutions - marketscreener.com
Thermo Fisher Scientific acquires Clario for nearly $8.9bn - Clinical Trials Arena
Thermo Fisher Scientific completes Clario Holdings acquisition - Medical Buyer
Thermo Fisher Scientific Inc. $TMO Stake Decreased by Professional Advisory Services Inc. - MarketBeat
U.S. Compound Management Market Is Going to Boom | Thermo Fisher - openPR.com
Thermo Fisher Scientific: Early Clario Close Enhances 2026 Growth Outlook and AI-Driven Competitive Position, Supporting Buy Rating - TipRanks
List of 55 Acquisitions by Thermo Fisher Scientific (Mar 2026) - Tracxn
Daymark Wealth Partners LLC Buys 7,003 Shares of Thermo Fisher Scientific Inc. $TMO - MarketBeat
PE investor group completes sale of clinical trial data firm Clario to Thermo Fisher for $8.9bn - pehub.com
Thermo Fisher Completes Strategic Acquisition of Clario Holdings - TipRanks
Thermo Fisher Scientific Inc. (TMO) announces the opening of cryo-electron microscopy drug discovery center in South San Francisco - MSN
Thermo Fisher Scientific Inc Stock (TMO) Moved Up by 3.15% on Mar 24: Facts Behind the Movement - TradingKey
Thermo Fisher Scientific Inc. 8-K Filing Details and Registered Securities Listing March 2026 - Minichart
Thermo Fisher Scientific Completes Acquisition of Clario Holdings, Inc. - PharmiWeb.com
Thermo Fisher Scientific (TMO) Completes Acquisition of Clario H - GuruFocus
Thermo Fisher Scientific (TMO) Partners With AIM ImmunoTech on Phase 3 Cancer Trial - Yahoo Finance
Thermo Fisher Scientific Inc. completed the acquisition of Clario Holdings, Inc. from a shareholder group led by Nordic Capital, Novo Holdings A/S, Astorg Asset Management S A.R.L., Cinven Limited and Partners Group Private Equity Limited, managed by Par - marketscreener.com
Thermo Fisher (TMO) Completes Acquisition of Clario Holdings - GuruFocus
Thermo Fisher Scientific Completes $8.88 Billion Acquisition of Clario - marketscreener.com
Thermo Fisher completes $8.9B acquisition of Clario - Investing.com
Thermo Fisher completes $8.9B acquisition of Clario By Investing.com - Investing.com Canada
Thermo Fisher Scientific completes acquisition of Clario Holdings, Inc. - marketscreener.com
Thermo Fisher Scientific Completes Acquisition Of Clario Holdings, Inc. - TradingView
Thermo Fisher completes $8.875B acquisition of Clario to boost clinical data offerings - TradingView
Thermo Fisher (NYSE: TMO) closes $8.875B Clario deal with EPS accretion - Stock Titan
Nordea Investment Management AB Decreases Stock Holdings in Thermo Fisher Scientific Inc. $TMO - MarketBeat
E. Ohman J or Asset Management AB Has $53.93 Million Holdings in Thermo Fisher Scientific Inc. $TMO - MarketBeat
Thermo Fisher Scientific Inc Azioni (TMO) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
3.47%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):